TD Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-34,766
Closed -$1.54M 1429
2022
Q4
$1.54M Sell
34,766
-9,456
-21% -$395K ﹤0.01% 1057
2022
Q3
$1.75M Sell
44,222
-3,695
-8% -$169K ﹤0.01% 1043
2022
Q2
$1.96M Sell
47,917
-9,900
-17% -$469K ﹤0.01% 1012
2022
Q1
$3.8M Sell
57,817
-21,888
-27% -$1.42M ﹤0.01% 891
2021
Q4
$5.54M Buy
79,705
+24,755
+45% +$1.8M ﹤0.01% 839
2021
Q3
$3.82M Sell
54,950
-400
-0.7% -$30.8K ﹤0.01% 895
2021
Q2
$4.67M Sell
55,350
-13,703
-20% -$996K ﹤0.01% 843
2021
Q1
$4.52M Buy
69,053
+4,754
+7% +$293K 0.01% 854
2020
Q4
$3.58M Sell
64,299
-4,967
-7% -$215K ﹤0.01% 880
2020
Q3
$2.76M Hold
69,266
﹤0.01% 835
2020
Q2
$3.11M Buy
69,266
+12,440
+22% +$542K ﹤0.01% 769
2020
Q1
$1.91M Sell
56,826
-2,300
-4% -$82.7K ﹤0.01% 846
2019
Q4
$1.92M Buy
59,126
+900
+2% +$25.6K ﹤0.01% 939
2019
Q3
$1.45M Buy
58,226
+3,000
+5% +$85.7K ﹤0.01% 984
2019
Q2
$1.65M Sell
55,226
-3,100
-5% -$90.5K ﹤0.01% 954
2019
Q1
$1.56M Sell
58,326
-300
-0.5% -$9.11K ﹤0.01% 953
2018
Q4
$1.79M Sell
58,626
-8,300
-12% -$259K ﹤0.01% 938
2018
Q3
$2.34M Buy
66,926
+2,326
+4% +$73.6K ﹤0.01% 950
2018
Q2
$1.75M Buy
64,600
+30,184
+88% +$709K ﹤0.01% 993
2018
Q1
$706K Buy
+34,416
New +$622K ﹤0.01% 1134

Other funds holding ATRC

TD Asset Management's ATRC Position: Q1 2023 in Review

TD Asset Management sold out of AtriCure (ATRC) in Q1 2023, closing a stake of 34,766 shares — an estimated $1.54M sold.

TD Asset Management first reported a position in ATRC in Q1 2018 and held it in 20 quarters. The position peaked at $5.54M in Q4 2021. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2023.

  • TD Asset Management reported no remaining AtriCure position as of Q1 2023 after selling out during the quarter.
  • TD Asset Management sold 34,766 AtriCure shares in Q1 2023, an estimated $1.54M.
  • TD Asset Management first reported a position in AtriCure in Q1 2018 and held it in 20 quarters.
  • TD Asset Management's AtriCure position peaked at $5.54M in Q4 2021.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2023.

Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.